Home
ILDong

ILDong Market Share Analysis for March 2026

제약회사. r&d 파이프라인, 아로나민, 비오비타, 지큐랩, 마이니 등 제품소개

Health > Biotechnology and Pharmaceuticals

Domainildong.com

Year Founded1941

Employees1001 - 5000

Annual Revenue$200M - $500M

ILDong

ILDong (including company regionals)

ildong.com

See more website traffic and engagement information

ILDong Revenue up to March 2026 is 200M - 500M

revenue generated by ILDong top domains

ILDong top domains revenue over 3 years

Revenue for ILDong top domains

ildong.com200M - 500M

See more with Sales Intelligence

Total visits to ILDong's top domains

Understand ILDong market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

ildong.com111K

See more with Sales Intelligence

Avg. visit duration in ILDong's top domains

Analyze ILDong engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

ildong.com00:04:03

See more with Sales Intelligence

Avg. pageviews on ILDong's top domains

See how ILDong keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

ildong.com4.25

See more with Sales Intelligence

ILDong top competitors by domain

Top similar sites in March 2026, ranked by their affinity

dkpharm.co.krCompany NameDONGKOOK PharmEmployees501 - 1000HQKorea, Republic of, SeoulAnnual revenue$200M - $500MTotal visits103.3KHealth > Biotechnology and Pharmaceuticals

Top technologies used by ILDong

These are the website technologies, by industry, used by ILDong top domains

Social (5)

Instagram

Advertising (4)

Google Adsense

Conversion & Analytics (3)

Google Analytics

Audio Video Media (1)

YouTube

More Technologies

4

See all

News & Signals from ILDong

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsIldong Pharmaceutical Co., Ltd. is developing antibodies for use in immuno-oncology on Jul 1st '23.In July last year, Twist announced a partnership with Ildong to develop antibodies for use in immuno-oncology.

NewsIldong Pharmaceutical Co., Ltd. is developing P-CAB -based treatment for gastroesophageal reflux disease.Ildong Pharmaceutical has jumped into developing P-CAB (potassium-competitive acid blockers)-based treatment for gastroesophageal reflux disease (GERD), drawing the industry’s attention to the market once again.